About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT05153694

Infectious Complications After Cystectomy: A Prospective Observational Study

Patients undergoing cystectomy for either oncological or non-oncological indications are prospectively enrolled following informed consent. This study design incorporates a comprehensive medical histo...

Lead sponsor: Ludwig-Maximilians - University of Munich•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Benedikt Ebner, Dr.

CONTACT

004917655197898 Benedikt.Ebner@med.uni-muenchen.de

Sponsors

Lead Sponsor

Ludwig-Maximilians - University of Munich

Aims of the study: 1. Prospective evaluation of the association between preoperative interleukin-6 levels and local tumor stage in patients undergoing radical cystectomy 2. Prospective assessment of interleukin-6, procalcitonin and wound drainage culture as early indicators for perioperative infectious complications after cystectomy 3. Prospective evaluation of physician-assessed vs. patient-reported grading of complications after cystectomy 4. Prospective comparison of infectious complications within the first 12 months after cystectomy: ileal neobladder vs. ileal conduit 5. Prospective evaluation of the association between in-hospital complications after cystectomy and quality of life after three months

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Disease which requires removal of the urinary bladder

Exclusion Criteria

•Patient does not want to participate

Related studies

Study of Mycobacterial Infections

NCT00018044 · Mycobacterium Infections

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more

RECRUITINGPhase 1

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT06257264 · Breast Cancer, Small Cell Lung Cancer, and more

RECRUITINGPhase 1

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

NCT07206225 · Non-muscle Invasive Bladder Cancer

RECRUITINGPhase 2

A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants

NCT07286370 · Salmonella Infections

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 19, 2024Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment200

Start dateDec 2021

Last updatedSep 19, 2024

Condition

Bladder Cancer Infections Infection, Bacterial Infection, Hospital Infection Wound+3 more

Locations shown

Urology Department - LMU Klinikum

Munich, Outside U.S./Canada

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 19, 2024Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions